Your search returned 2 results.

Results
	1.	Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells. [electronic resource] by He, Chang-xi Ai, Jing Xing, Wei-qiang Chen, Yi Zhang, Hao-tian Huang, Min Hu, You-hong Ding, Jian Geng, Mei-yu Producer: 20140714 In: Acta pharmacologica Sinica vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	SOMG-833, a novel selective c-MET inhibitor, blocks c-MET-dependent neoplastic effects and exerts antitumor activity. [electronic resource] by Zhang, Hao-tian Wang, Lu Ai, Jing Chen, Yi He, Chang-xi Ji, Yin-chun Huang, Min Yang, Jing-yu Zhang, Ao Ding, Jian Geng, Mei-yu Producer: 20140826 In: The Journal of pharmacology and experimental therapeutics vol. 350 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search